US Stem Cell (USRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,482 | -2,070 | -1,642 | -2,254 | -3,143 |
| Depreciation Amortization | 305 | 6 | 5 | 5 | 2 |
| Accounts receivable | -44 | 13 | 22 | -104 | -19 |
| Accounts payable and accrued liabilities | 469 | 11 | 435 | 858 | -59 |
| Other Working Capital | 1,711 | 1,155 | 868 | 1,859 | 1,196 |
| Other Operating Activity | 2,271 | 998 | -532 | -1,473 | 110 |
| Operating Cash Flow | $1,231 | $112 | $-845 | $-1,109 | $-1,913 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 399 | -12 | -2 | -8 | -9 |
| Purchase Of Investment | 225 | 175 | -10 | -50 | N/A |
| Other Investing Activity | 100 | 0 | -222 | 0 | 0 |
| Investing Cash Flow | $724 | $163 | $-234 | $-58 | $-9 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 15 | 784 | 774 | 631 |
| Debt Issued | 155 | 523 | N/A | N/A | N/A |
| Debt Repayment | -1,139 | -267 | N/A | N/A | N/A |
| Common Stock Issued | 275 | 60 | 583 | 616 | 1,427 |
| Common Stock Repurchased | N/A | -8 | N/A | N/A | N/A |
| Other Financing Activity | -530 | -386 | -266 | -233 | -89 |
| Financing Cash Flow | $-1,239 | $-63 | $1,100 | $1,157 | $1,969 |
| Beginning Cash Position | 271 | 58 | 37 | 46 | N/A |
| End Cash Position | 987 | 271 | 58 | 37 | 46 |
| Net Cash Flow | $716 | $212 | $22 | $-10 | $46 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,231 | 112 | -845 | -1,109 | -1,913 |
| Capital Expenditure | -1 | -13 | -2 | -8 | -9 |
| Free Cash Flow | 1,230 | 100 | -847 | -1,117 | -1,923 |